2mzl
From Proteopedia
(Difference between revisions)
												
			
			| Line 1: | Line 1: | ||
| - | ''' | + | ==The Solution Structure of the Magnesium-bound Conantokin-G Mutant== | 
| + | <StructureSection load='2mzl' size='340' side='right' caption='[[2mzl]], [[NMR_Ensembles_of_Models | 10 NMR models]]' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[2mzl]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2MZL OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2MZL FirstGlance]. <br> | ||
| + | </td></tr><tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=CGU:GAMMA-CARBOXY-GLUTAMIC+ACID'>CGU</scene>, <scene name='pdbligand=HYP:4-HYDROXYPROLINE'>HYP</scene>, <scene name='pdbligand=NH2:AMINO+GROUP'>NH2</scene></td></tr> | ||
| + | <tr id='related'><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[2myz|2myz]], [[2mzk|2mzk]], [[2mzm|2mzm]]</td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=2mzl FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2mzl OCA], [http://www.rcsb.org/pdb/explore.do?structureId=2mzl RCSB], [http://www.ebi.ac.uk/pdbsum/2mzl PDBsum]</span></td></tr> | ||
| + | </table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Conantokins are ~20 amino acid peptides present in predatory marine snail venoms that function as allosteric antagonists of ion channels of the N-methyl-D-aspartate receptor (NMDAR). These peptides possess a high percentage of post-/co-translationally modified amino acids, particularly gamma-carboxyglutamate (Gla). Appropriately spaced Gla residues allow binding of functional divalent cations, which induces end-to-end alpha-helices in many conantokins. A smaller number of these peptides additionally contain 4-hydroxyproline (HyP). HyP should prevent adoption of the metal ion-induced full alpha-helix, with unknown functional consequences. To address this disparity, as well as the role of HyP in conantokins, we have solved the high-resolution 3D-solution structure of a Gla/HyP-containing 18-residue conantokin, conRl-B, by high-field NMR spectroscopy. We show that HyP10 disrupts only a small region of the alpha-helix of the Mg2+/peptide complex, which displays cation-induced alpha-helices on each terminus of the peptide. The function of conRl-B was examined by measuring its inhibition of NMDA/Gly-mediated current through NMDAR ion channels in mouse cortical neurons. ConRl-B displays high inhibitory selectivity for subclasses of NMDARs that contain the functionally important GluN2B subunit. Replacement of HyP10 with N8Q results in a Mg2+-complexed end-to-end alpha-helix, accompanied by attenuation of NMDAR inhibitory activity. However, replacement of HyP10 with Pro10 allowed the resulting peptide to retain its inhibitory property, but diminished its GluN2B-specificity. Thus, these modified amino acids, in specific peptide backbones, play critical roles in their subunit-selective inhibition of NMDAR ion channels, a finding that can be employed to design NMDAR antagonists that function at ion channels of distinct NMDAR subclasses. | ||
| - | + | Hydroxyproline-induced Helical Disruption in Conantokin Rl-B Affects Subunit-selective Antagonistic Activities Toward Ion Channels of NMDA Receptors.,Kunda S, Yuan Y, Balsara RD, Zaijcek J, Castellino FJ J Biol Chem. 2015 Jun 5. pii: jbc.M115.650341. PMID:26048991<ref>PMID:26048991</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | + | == References == | |
| - | [[Category:  | + | <references/> | 
| + | __TOC__ | ||
| + | </StructureSection> | ||
| + | [[Category: Balsara, R D]] | ||
| + | [[Category: Castellino, F J]] | ||
| [[Category: Kunda, S]] | [[Category: Kunda, S]] | ||
| - | [[Category: Balsara, R.D]] | ||
| [[Category: Yuan, Y]] | [[Category: Yuan, Y]] | ||
| - | [[Category: Castellino, F.J]] | ||
| [[Category: Zajicek, J]] | [[Category: Zajicek, J]] | ||
| + | [[Category: Hyp-containing]] | ||
| + | [[Category: Metal binding protein]] | ||
| + | [[Category: Nmdar antagonist]] | ||
| + | [[Category: Toxin]] | ||
| + | [[Category: Transport protein inhibitor]] | ||
Revision as of 15:16, 17 June 2015
The Solution Structure of the Magnesium-bound Conantokin-G Mutant
| 
 | |||||||||||
